Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuraxis (NRXS) Invested Capital (2022 - 2025)

Historic Invested Capital for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to $2.3 million.

  • Neuraxis' Invested Capital rose 22737.05% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 22737.05%. This contributed to the annual value of $2.1 million for FY2024, which is 24735.52% up from last year.
  • Per Neuraxis' latest filing, its Invested Capital stood at $2.3 million for Q3 2025, which was up 22737.05% from $4.3 million recorded in Q2 2025.
  • Neuraxis' Invested Capital's 5-year high stood at $4.3 million during Q2 2025, with a 5-year trough of -$7.7 million in Q2 2023.
  • For the 4-year period, Neuraxis' Invested Capital averaged around -$1.4 million, with its median value being -$1.4 million (2023).
  • The largest annual percentage gain for Neuraxis' Invested Capital in the last 5 years was 24735.52% (2024), contrasted with its biggest fall of 6906.55% (2024).
  • Quarter analysis of 4 years shows Neuraxis' Invested Capital stood at -$3.8 million in 2022, then surged by 63.44% to -$1.4 million in 2023, then soared by 247.36% to $2.1 million in 2024, then increased by 10.5% to $2.3 million in 2025.
  • Its Invested Capital was $2.3 million in Q3 2025, compared to $4.3 million in Q2 2025 and $258479.0 in Q1 2025.